Results 31 to 40 of about 202,042 (259)

Case Report: Amphotericin B and Mefloquine as a Salvage Treatment of Alveolar Echinococcosis.

open access: yesAmerican Journal of Tropical Medicine and Hygiene, 2023
Alveolar echinococcosis is an emerging zoonotic disease caused by the parasite Echinococcus multilocularis. Most patients are diagnosed at a late stage, when lifelong treatment with benzimidazoles is required to stop disease progression.
Karlo Jeličić   +3 more
semanticscholar   +1 more source

Can contrast-enhanced ultrasound differentiate the type of hepatic echinococcosis: cystic echinococcosis or alveolar echinococcosis?

open access: yesParasites & Vectors, 2023
Background Hepatic echinococcosis (HE) is a zoonotic disease caused by Echinococcus , and Echinococcus granulosus and E. multilocularis are the most common, causing cystic echinococcosis (CE) and alveolar echinococcosis (AE), respectively.
Xuhui Zhang   +10 more
semanticscholar   +1 more source

Molecular diagnosis of alveolar echinococcosis in patients based on frozen and formalin-fixed paraffin-embedded tissue samples

open access: yesParasite, 2022
Confirmed diagnosis of alveolar echinococcosis (AE) is based on pathological criteria and molecular evidence. This parasite-borne disease, caused by the cestode Echinococcus multilocularis, sparingly involves humans as a dead-end host.
J. Knapp   +13 more
semanticscholar   +1 more source

Dog Ownership and Risk for Alveolar Echinococcosis, Germany

open access: yesEmerging Infectious Diseases, 2022
Human alveolar echinococcosis is caused by the parasite Echinococcus multilocularis, and dog ownership has been identified as a risk factor. We sought to specify the factors of dog ownership underlying this risk by conducting a case–control study among ...
J. Schmidberger   +6 more
semanticscholar   +1 more source

Hepatic alveolar echinococcosis [PDF]

open access: yesActa Chirurgica Belgica, 2018
A 79-year old female patient with past history of breast adenocarcinoma underwent an abdominal computed tomography (CT) for asthenia and nausea.
Jean Delwaide   +9 more
openaire   +2 more sources

Imaging Aspects of Hepatic Alveolar Echinococcosis: Retrospective Findings of a Surgical Center in Turkey

open access: yesPathogens, 2022
Radiologists should be aware of the findings of alveolar echinococcosis (AE) due to the diagnostic and management value of imaging. We are attempting to define the most common diagnostic imaging findings of liver AE, along with the prevalence and ...
M. Kantarci   +4 more
semanticscholar   +1 more source

Stage-Oriented CT Classification and Intermodal Evolution Model in Hepatic Alveolar Echinococcosis

open access: yesRöFo. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (Print), 2022
Background Alveolar echinococcosis (AE) is one of the most dangerous human parasitoses. The main site of disease manifestation is the liver (about 98 %).
T. Graeter, J. Schmidberger
semanticscholar   +1 more source

Label-free intratissue activity imaging of alveolar organoids with dynamic optical coherence tomography [PDF]

open access: yesBiomedical Optics Express 14, 2333-2351 (2023), 2023
An organoid is a three-dimensional (3D) in vitro cell culture emulating human organs. We applied 3D dynamic optical coherence tomography (DOCT) to visualize the intratissue and intracellular activities of human induced pluripotent stem cells (hiPSCs)-derived alveolar organoids in normal and fibrosis models.
arxiv   +1 more source

Contrast-enhanced ultrasound (CEUS) in patients with metastasis-like hepatic alveolar echinococcosis: a cohort study

open access: yesJournal of Ultrasound, 2022
Purpose Hepatic alveolar echinococcosis (HAE) of the metastasis-like pattern, according to the Echinococcus Ulm classification, is usually discovered as an incidental finding, and the diagnostic differentiation from “true metastases” is difficult.
M. Schweizer   +3 more
semanticscholar   +1 more source

Salvage Therapy for Alveolar Echinococcosis—A Case Series

open access: yesPathogens, 2022
Benzimidazoles are the only approved drugs for the treatment of inoperable human alveolar echinococcosis but may be limited due to intolerance or, rarely, ineffectiveness.
Sanne Burkert   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy